IMM.L
ImmuPharma Plc
Latest RNS
Powered by
Vox Markets
Immupharma PLC - Finals results for y/e 31 December 2021
more
Immupharma PLC - UPDATE on LUPUZOR™ PROGRESS to PHASE 3 with AVION
more
Immupharma PLC - UPDATE on P140 (LUPUZOR™) clinical progress
more
Immupharma PLC - LUPUZOR UPDATE
more
Immupharma PLC - TR-1: Notification of major holdings
more
Immupharma PLC - TR-1: Notification of major holdings
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Subscriptions and Placing to raise £3.55 million
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - COLLABORATION WITH IMPERIAL COLLEGE LONDON
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Euronext Delisting
more
Immupharma PLC - Euronext Delisting
more
Immupharma PLC - PROF. SYLVIANE MULLER AWARDED ‘LEGION D’HONNEUR’
more
Immupharma PLC - Interim Results for the 6months ended 30 June 2021
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Director/PDMR Shareholding
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Notification of Major Holdings
more
Immupharma PLC - FDA approves the Lupzuor™ PK study
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Board Changes
more
Immupharma PLC - Board Appointment
more
Immupharma PLC - 2021 RESULT OF ANNUAL GENERAL MEETING -REPLACEMENT
more
Immupharma PLC - 2021 RESULT OF ANNUAL GENERAL MEETING
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Update: Lupzuor™ PK study
more
Immupharma PLC - Notice of AGM and posting of Report & Accounts
more
Immupharma PLC - Director Retirement
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Final Results
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Update- scheduled Phase 3 trials in lupus patients
more
Immupharma PLC - Appointment of Company Secretary
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - IMM TO PRESENT AT BIOTECH SHOWCASE DIGITAL 2021
more
Immupharma PLC - Total Share Capital Notification
more
Immupharma PLC - Grant of Share Options & PDMR dealing
more
Immupharma PLC - Conversion of Convertible Security
more
Immupharma PLC - Conversion of Convertible Security
more
Immupharma PLC - Update : FDA confirms 4 Dec for Type ‘A’ meeting
more
Immupharma PLC - Total Share Capital Notification - Replacement
more
Immupharma PLC - Update on submission to the FDA
more
Immupharma PLC - Total Share Capital Notification
more
Immupharma PLC - Interim Results
more
Immupharma PLC - Share Subscription into Incanthera plc
more
Immupharma PLC - Repayment of Convertible Security
more
Immupharma PLC - Update on submission to the FDA
more
Immupharma PLC - Conversion of Convertible Security
more
Immupharma PLC - Conversion of Convertible Security
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Director/PDMR Shareholding / TR -1
more
Immupharma PLC - Placing - update; related party transaction)
more
Immupharma PLC - Conversion of Convertible Security
more
Immupharma PLC - Placing to raise £6.5 million
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - FDA submission for Special Protocol Assessment
more
Immupharma PLC - 2020 AGM – ALL RESOLUTIONS PASSED
more
Immupharma PLC - Total Share Capital Notification
more
Immupharma PLC - TR-1 Notification of major holdings
more
Immupharma PLC - STRAT. INVTS FROM 2 SPECIALIST US H'CARE INVESTORS
more
Immupharma PLC - Change of Registered Office Address
more
Immupharma PLC - Notification of Change of AGM Venue
more
Immupharma PLC - Notice of AGM and posting of Report & Accounts
more
Immupharma PLC - TR-1: Notification of major holdings
more
Immupharma PLC - Efforts in fight vs Covid-19 with Lupuzor; Ureka
more
Immupharma PLC - Audited Report & Accounts published on website
more
Immupharma PLC - FINAL RESULTS FOR THE 12M ENDED 31/12/19
more
Immupharma PLC - IMM live on Investor Meet Company platform 7 April
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - £1.5m Subscrip'n to fund R&D pipeline- replacement
more
Immupharma PLC - £1.5m Subscription to fund R&D pipeline expansion
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Incanthera plc – Admission to trading on NEX
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Incanthera announces Rule 23 Notice re NEX listing
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Update on the Avion Agreement
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Admission today to trading on Euronext Growth
more
Immupharma PLC - Publication of Information Note (Euronext Growth)
more
Immupharma PLC - Dual Listing on Euronext Growth Brussels
more
Immupharma PLC - Share Price Volatility
more
Immupharma PLC - IMMUPHARMA TO PRESENT AT BIOTECH SHOWCASET 2020
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - Licence Agreement for Lupuzor with Avion in US
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Interim Results Announcement
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - Update on Lupuzor
more
Immupharma PLC - 2019 Annual General Meeting
more
Immupharma PLC - Subscription to raise £2.66 million
more
Immupharma PLC - Notice of AGM and posting of Report & Accounts
more
Immupharma PLC - FINAL RESULTS
more
Immupharma PLC - Corporate Update - Replacement
more
Immupharma PLC - Corporate Update - Replacement
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Update on Nucant Cancer Programme
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Technology review published-Nature Communications
more
Immupharma PLC - Clinical Development Collaboration with Incanthera
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Appointment of Nominated Adviser
more
Immupharma PLC - Update on Corporate Activities
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Nominated Adviser Status
more
Immupharma PLC - Interim Results
more
Immupharma PLC - Appointment of Joint Brokers
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Result of AGM
more
Immupharma PLC - Results of CIDP Pre-Clinical Data
more
Immupharma PLC - Notice of AGM & Posting of Annual Report
more
Immupharma PLC - Final Results
more
Immupharma PLC - Update on Pivotal Phase III Trial of Lupuzor
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Topline results of Lupuzor Pivotal Phase III Trial
more
Immupharma PLC - Appointment of Joint Broker
more
Immupharma PLC - Lupuzor Pivotal Phase III Study Update
more
Immupharma PLC - AIM Notice (17)
more
Immupharma PLC - Grant of Options
more
Immupharma PLC - Last patient completes dosing in LupuzorT Trial
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Grant of Options
more
Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Completion of Lanstead Sharing Agreement
more
Immupharma PLC - Interim Results
more
Immupharma PLC - Preparation of Lupuzor'sT Regulatory Submissions
more
Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
more
Immupharma PLC - Notification of Interim Results
more
Immupharma PLC - AIM Rule 17 Notice
more
Immupharma PLC - Grant of Options
more
Immupharma PLC - Result of AGM
more
Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
more
Immupharma PLC - Annual Report & Notice of AGM
more
Immupharma PLC - Final Results
more